Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
HUYA Bioscience International has announced the appointment of Akira Miyazato, MD, Ph.D. as VP, Head of Clinical Research and Development in Japan.
read more
Sterling Pharma Solutions, is investing $1.5 million into a phased expansion of its US facility in North Carolina.
read more
Review the latest news and information on the COVID-19 Pandemic.
read more
Thursday, September 17, 2015
AbbVie in cooperation with Neurocrine Biosciences, Inc. has announced the completion of a Phase 2b clinical trial evaluating the safety and efficacy of elagolix alone or in combination with add-back therapy compared to placebo
read more
Thursday, December 21, 2017
Merck announced the IP Office of Singapore has issued a "Notice of Eligibility for Grant" for Merck's patent application covering the company's CRISPR technology used in a genomic-integration method for eukaryotic cells.
read more
BioReference Laboratories, an OPKO Health company, is now accepting specimens for a new multiplex COVID-19 and influenza test.
read more
Wednesday, April 14, 2021
A Commercial State-of-the-art Research Laboratory Delivering Histopathology And Precision Medicine Services For Global Clinical Trials.
read more
Ligand has entered into a commercial license and supply agreement with Amgen, granting rights to use Ligand’s Captisol technology in the formulation of AMG 330.
read more
Wednesday, August 23, 2017
WuXi Biologics announces its unaudited interim results for the six months ended June 30, 2017.
read more
Samsung Bioepis announced the FDA has approved HADLIMA™ (adalimumab-bwwd), a biosimilar referencing HUMIRA® (adalimumab).
read more
Tuesday, December 22, 2020
Aprecia is partnering with Battelle to accelerate and expand its advanced capabilities in 3DP pharmaceutical manufacturing.
read more
More than half of all image-related clinical trial query stoppages result from preventable human errors, according to industry research. In response, AG Mednet announces its “Submission Quality & Compliance” module that delivers a new layer of ...
read more
Thursday, February 07, 2019
Marken announced they have developed an automated closed loop packaging solution that allows clinical trial materials to travel at any temperature to any destination with an integrated and automated packaging returns process.
read more
Friday, December 09, 2022
Emmes announced the creation of a dedicated center to enhance Emmes’ legacy and depth in cell and gene therapy research.
read more
ProTrials Research, Inc., has announced the awarding and initiation of an agreement with Calithera Biosciences Inc., a clinical stage biotechnology company focused on the discovery and development of novel small molecule drugs directed against tumor ...
read more